Screener
AtriCure ATRC Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from AtriCure’s reported figures.
Based on trailing twelve months.
The source filing: AtriCure’s 10-Q, filed October 30, 2025. Open the filing →
- Filed
- Oct 30, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001323885-25-000103
FAQ
- What is AtriCure's return on equity?
- AtriCure (ATRC) reported return on equity of -6.1% in Q3 2025.
- How has AtriCure's return on equity changed year-over-year?
- AtriCure's return on equity increased by 27.1% year-over-year, from -8.4% to -6.1%.
- What is the long-term trend for AtriCure's return on equity?
- Over 3 years (2020 to 2024), AtriCure's return on equity has grown at a -12.9% compound annual growth rate (CAGR), from -14.6% to -9.6%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about AtriCure's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude